ResMed | RMD - Debt



ResMed reported $668.29M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Ansell USD 857.2M 352.1M Jun/2024
AtriCure USD 77.25M 15.39M Jun/2025
Baxter International USD 10.31B 2.82B Mar/2025
Cochlear AUD 246.6M 2.9M Dec/2024
Cooper Companies USD 2.48B 107.1M Jul/2025
CSL USD 11.96B 219M Dec/2024
Dexcom USD 2.58B 78.4M Jun/2025
Edwards Lifesciences USD 699.4M 101.7M Mar/2025
Fisher Paykel Healthcare NZD 153.3M 2.4M Mar/2025
Globus Medical USD 477K 443.4M Mar/2025
Haemonetics USD 1.22B 6K Jun/2025
Hologic USD 2.52B 8.5M Jun/2025
Idexx Laboratories USD 1.24B 297.04M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 642.2M 8.8M Jun/2025
Medtronic USD 28.52B 1.91B Apr/2025
Philips EUR 8.43B 857M Jun/2025
Ramsay Health Care AUD 11.26B 317.4M Dec/2024
ResMed USD 668.29M 4.74M Jun/2025
Sigma Healthcare AUD 137.64M 1.01M Jul/2024
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Steris USD 2.04B 120.02M Mar/2025
Teleflex USD 2B 9.83M Jun/2025
Thermo Fisher Scientific USD 34.19B 2.91B Mar/2025